asthma, cystic fibrosis, clinical trials, transition to adult care, quality improvement, patient safety
Board Certified in Pediatrics and Pediatric Pulmonology
Society for Pediatric Research, American Academy of Pediatrics, American Thoracic Society
Honors and Awards
Best Doctors in America
Notable Publications and Presentations
1.Urte Sommerwerck, Isabel Virella-Lowell, Gerhild Angyalosi Andrea Viegas, Weihua Cao, Laurie Debonnett. Long-term Safety of Tobramycin Powder for Inhalation in Cystic Fibrosis Patients: Results from a Phase IV (ETOILES) Study. Curr Med Res Opin. 2016 Jul 20:1-2
2. S Morrow Buff, H Yu, J McCall, S Caldwell, T Ferkol, T Flotte, and I Virella-Lowell. IL-10 delivery by adeno-associated vector attenuates inflammation in mice with Pseudomonas pneumonia. Gene Ther. 2010 May;17(5):567-76.
3. H Yu, Y Zeidan, B Wu, T Flotte, Y Hannun, and I Virella-Lowell. Loss of induction of acid sphingomyelinase is associated with persistent pseudomonas aeruginosa infection in cystic fibrosis. Am J Respir Cell Mol Biol. (2009) Jan 23.
4. Jennifer L Wentzel, MS, Isabel Virella-Lowell, MD, Zachary M. Soler, MD, MSc. Quantitative sinonasal symptom assessment in an unselected pediatric population with cystic fibrosis. Am J Rhinol Allergy. 2015 Sep-Oct;29(5):357-61.
5. sabel Virella-Lowell, Amy Poirier, Kye A. Chesnut, Mark Brantly, and Terence R. Flotte. Inhibition of Recombinant Adeno-associated Virus (rAAV) Transduction by Bronchial Secretions From Cystic Fibrosis Patients. Gene Ther 2000. 7(20)1783-1789.